Readystate Asset Management LP lifted its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) by 75.4% during the second quarter, HoldingsChannel reports. The firm owned 113,932 shares of the company’s stock after acquiring an additional 48,962 shares during the quarter. Readystate Asset Management LP’s holdings in Bath & Body Works were worth $2,635,000 as of its most recent SEC filing.
Several other large investors also recently made changes to their positions in BBWI. Global Retirement Partners LLC bought a new position in shares of Bath & Body Works in the 4th quarter valued at about $31,000. Geneos Wealth Management Inc. lifted its stake in Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares during the last quarter. Parallel Advisors LLC lifted its stake in Bath & Body Works by 42.6% in the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock valued at $38,000 after purchasing an additional 567 shares during the last quarter. Danske Bank A S bought a new position in Bath & Body Works during the third quarter worth about $39,000. Finally, Elevation Wealth Partners LLC boosted its stake in shares of Bath & Body Works by 5,278.8% during the 2nd quarter. Elevation Wealth Partners LLC now owns 1,775 shares of the company’s stock worth $41,000 after acquiring an additional 1,742 shares during the period. Institutional investors and hedge funds own 95.14% of the company’s stock.
Wall Street Analyst Weigh In
A number of brokerages have recently weighed in on BBWI. The Goldman Sachs Group lowered Bath & Body Works from a “neutral” rating to a “sell” rating and lowered their target price for the stock from $23.00 to $19.00 in a research note on Wednesday, July 8th. TD Cowen lifted their price objective on shares of Bath & Body Works from $20.00 to $25.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. UBS Group dropped their price objective on Bath & Body Works from $19.00 to $17.00 and set a “neutral” rating for the company in a research report on Thursday, August 27th. Deutsche Bank Aktiengesellschaft set a $22.00 price objective on Bath & Body Works in a research note on Thursday, August 27th. Finally, Robert W. Baird lowered their target price on Bath & Body Works from $25.00 to $23.00 and set a “neutral” rating for the company in a research note on Thursday, August 27th. Four analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $22.29.
Bath & Body Works Price Performance
Shares of NYSE BBWI opened at $19.56 on Monday. The company has a 50 day simple moving average of $20.06 and a 200 day simple moving average of $19.80. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $32.03. The firm has a market cap of $3.94 billion, a PE ratio of 5.09, a price-to-earnings-growth ratio of 2.01 and a beta of 1.38.
Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its earnings results on Wednesday, August 26th. The company reported $0.62 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.38. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The firm had revenue of $1.51 billion for the quarter, compared to analyst estimates of $1.50 billion. During the same period in the previous year, the firm posted $0.30 EPS. The company’s revenue for the quarter was down 2.3% compared to the same quarter last year. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. As a group, research analysts anticipate that Bath & Body Works, Inc. will post 2.73 earnings per share for the current fiscal year.
Bath & Body Works Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 4th. Investors of record on Friday, August 21st were paid a $0.20 dividend. The ex-dividend date of this dividend was Friday, August 21st. This represents a $0.80 annualized dividend and a dividend yield of 4.1%. Bath & Body Works’s payout ratio is currently 20.83%.
About Bath & Body Works
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
Featured Articles
- Five stocks we like better than Bath & Body Works
- AI Token Costs Are Changing the Hardware vs. Software Debate
- 3 ETFs That Could Move as Rate Expectations Shift
- 3 Stocks With September Catalysts Investors Shouldn’t Ignore
- Ollie’s Bargain Outlet Stock Falls on Weak Comps Despite Margin Gains
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
